Modern Diagnostic & Research Centre Ltd
Modern Diagnostic & Research Centre Ltd (MDRC) last reported results for the quarter ended Mar 2026, with sales of ₹39.92 crore and net profit of ₹2.08 crore. The stock last traded at ₹68, a market capitalisation of ₹103 crore, on a P/E of 19.6. Over the past 52 weeks the stock has ranged between ₹45 and ₹100. Figures are as of 6 Oct 2026 and are not real time.
Modern Diagnostic & Research Centre Ltd share price and key metrics
- Current price
- ₹68
- Market cap
- ₹103 cr
- Stock P/E
- 19.6
- Book value
- ₹38.8
- ROE
- 13.2%
- ROCE
- 12.5%
- Dividend yield
- 0.00%
- 52w high / low
- 100/45.0
Metrics as of 6 Oct 2026. Not real time.
Track Modern Diagnostic & Research Centre Ltd
Cruxal reads every Modern Diagnostic & Research Centre Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Modern Diagnostic & Research Centre Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 14%
- TTM
- 7%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 43%
- TTM
- -42%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- %
- 10 Years
- %
- 5 Years
- 15%
- 3 Years
- 31%
- Last Year
- 13%
Modern Diagnostic & Research Centre Ltd quarterly results
| ₹ crore | Mar 2026 |
|---|---|
| Sales | 39.92 |
| Expenses | 34.84 |
| Operating profit | 5.08 |
| OPM % | 12.73% |
| Other income | 0.41 |
| Interest | 1.46 |
| Depreciation | 2.83 |
| Profit before tax | 1.2 |
| Tax % | -73.33% |
| Net profit | 2.08 |
| EPS (₹) | 1.38 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Modern Diagnostic & Research Centre Ltd annual results
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 60.21 | 56.28 | 67.13 | 77.95 | 83.11 |
| Operating profit | 6.02 | -0.98 | 11.14 | 18.11 | 12.81 |
| OPM % | 10.00% | -1.74% | 16.59% | 23.23% | 15.41% |
| Net profit | -1.45 | -5.73 | 5.79 | 9.01 | 5.25 |
| EPS (₹) | -14.50 | -57.30 | 57.90 | 8.19 | 3.48 |
TTM is the trailing twelve months to the most recent quarter.
Modern Diagnostic & Research Centre Ltd balance sheet
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 1.00 | 1.00 | 1.00 | 11.00 | 15.10 |
| Reserves | 10.70 | 4.96 | 10.76 | 9.77 | 43.45 |
| Borrowings | 20.40 | 15.31 | 20.46 | 22.09 | 37.10 |
| Other liabilities | 16.60 | 15.27 | 17.26 | 21.71 | 22.95 |
| Total liabilities | 48.70 | 36.54 | 49.48 | 64.57 | 118.60 |
| Fixed assets | 24.31 | 23.67 | 27.04 | 30.65 | 48.09 |
| CWIP | 0.75 | 0.00 | 3.60 | 9.11 | 10.18 |
| Investments | 5.29 | 0.11 | 0.21 | 0.23 | 16.97 |
| Other assets | 18.35 | 12.76 | 18.63 | 24.58 | 43.36 |
| Total assets | 48.70 | 36.54 | 49.48 | 64.57 | 118.60 |
As reported by the company. Total assets equal total liabilities by construction.
Modern Diagnostic & Research Centre Ltd cash flow
| ₹ crore | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operations | 3.64 | -0.12 | 7.93 | 13.90 | 3.82 |
| Cash from investing | -5.20 | 2.11 | -11.03 | -13.31 | -40.29 |
| Cash from financing | 4.50 | -6.47 | 3.36 | -0.22 | 45.08 |
| Net cash flow | 2.94 | -4.48 | 0.26 | 0.37 | 8.62 |
| Free cash flow | -1.49 | -3.27 | -3.04 | 0.58 | -19.88 |
| CFO / operating profit | 52% | 12% | 60% | 98% | 36% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Modern Diagnostic & Research Centre Ltd operating ratios
| Per year | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | — | -17.24% | 32.75% | 39.37% | 12.48% |
| Debtor days | 54.56 | 52.27 | 56.28 | 59.75 | 69.30 |
| Inventory days | 25.90 | 40.62 | 61.45 | 95.47 | 119.58 |
| Days payable | 172.38 | 170.83 | 177.12 | 160.28 | 196.43 |
| Cash conversion cycle | -91.92 | -77.94 | -59.39 | -5.06 | -7.55 |
| Working capital days | -43.95 | -58.82 | -34.74 | -37.79 | -41.68 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Modern Diagnostic & Research Centre Ltd shareholding pattern
| % held | Mar 2026 |
|---|---|
| Promoters | 72.85% |
| FIIs | 0.03% |
| DIIs | 15.49% |
| Public | 11.63% |
| No. of shareholders | 282 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Modern Diagnostic & Research Centre Ltd corporate filings
- Moderate Market Reaction Anticipated to AGM Voting Results of Modern Diagnostic & Research Centre LimitedAGM/EGMmedium impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited has successfully passed all three ordinary…
Read the full analysis - No financial or strategic updates; AGM summary indicates routine proceedings of Modern Diagnostic & Research Centre Limited held on September 30, 2026AGM/EGMlow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited conducted its 14th AGM on September 30, 2026…
Read the full analysis - Intimation regarding of closure of trading window for the half year ending on 30.09.2026Insider Trading / SASTlow impact
- Modern Diagnostic & Research Centre Ltd clarifies on recent stock price movementCompany Updatelow impact
Cruxal's analysis: The company has issued a clarification regarding the recent significant movement in its…
Read the full analysis - Modern Diagnostic & Research Centre Limited schedules 14th Annual General Meeting for September 30, 2026Company Updatelow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited has formally notified the BSE regarding the…
Read the full analysis - Modern Diagnostic & Research Centre Ltd submits Annual Report for FY 2025-26 and announces 14th AGMOtherslow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Ltd has filed its Annual Report for the financial…
Read the full analysis - Modern Diagnostic & Research Centre Limited Announces 14th Annual General Meeting and Book Closure DatesAGM/EGMlow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited has formally intimated the scheduling of its…
Read the full analysis - Modern Diagnostic & Research Centre Ltd announces revised book closure dates for September 2026Corp. Actionlow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Ltd has issued a corrigendum regarding the book…
Read the full analysis - Modern Diagnostic & Research Centre Ltd announces revised record date of 23.09.2026Corp. Actionlow impact
Cruxal's analysis: The company has issued a corrigendum regarding a corporate action, formally notifying…
Read the full analysis - Modern Diagnostic & Research Centre Limited schedules 14th Annual General Meeting for September 30, 2026Corp. Actionlow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited has announced that its 14th Annual General…
Read the full analysis - Modern Diagnostic & Research Centre Ltd announces AGM record date for September 23, 2026Corp. Actionlow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Ltd has formally notified the exchange that the…
Read the full analysis - Modern Diagnostic & Research Centre Limited appoints Scrutinizer for 14th Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited has formally appointed M/s. Kuldeep Bisht &…
Read the full analysis - Modern Diagnostic & Research Centre Limited Announces Board Meeting Outcomes and Termination of Jaipur Laboratory AgreementBoard Meetinglow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited has disclosed the outcomes of its board…
Read the full analysis - Modern Diagnostic & Research Centre Limited schedules Board Meeting for September 3, 2026Board Meetinglow impact
Cruxal's analysis: Modern Diagnostic & Research Centre Limited has announced a board meeting scheduled for…
Read the full analysis - Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for quarter ended June 30, 2026Company Updatelow impact
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.